The increased expression of TYK2 gene indicated worse overall survival outcomes in ACC, LAML, and PRAD, while the increased expression of TYK2 gene indicated better overall survival outcomes in PAAD. This evidence concerns the gene TYK2 and adrenal cortex carcinoma.